衰老、氧化应激与白内障:过氧化物还原酶6的治疗前景与转化见解
本文综述了过氧化物还原酶6(Prdx6)在氧化应激和衰老过程中调控细胞死亡与存活的机制及其与白内障形成的关系。Prdx6具有谷胱甘肽过氧化物酶、酸性钙非依赖性磷脂酶A2和溶血磷脂酰胆碱酰基转移酶活性,并通过促进硒利用和硒蛋白表达(尤其是GPx4)抑制铁死亡。增强Prdx6活性被认为是预防或逆转年龄相关性白内障的潜在策略。
要点
- Prdx6缺失或翻译后氧化修饰异常会破坏细胞稳态,触发凋亡和焦亡等细胞死亡。
- Prdx6通过增强硒蛋白(尤其GPx4)表达和活性来抑制铁死亡。
- 靶向Prdx6的天然激活剂可能延缓或预防年龄相关性白内障。
核心结论
- 增强Prdx6活性是预防或逆转年龄相关性白内障的有前景策略。
研究设计与样本
- 本文为综述,总结Prdx6在氧化应激和衰老中的调控与活性及其与白内障形成的关系。
主要发现
- Prdx6具有谷胱甘肽过氧化物酶、酸性钙非依赖性磷脂酶A2和溶血磷脂酰胆碱酰基转移酶活性,可减少活性氧。
- Prdx6缺失或氧化修饰异常会破坏细胞稳态,触发凋亡和焦亡等细胞死亡。
- Prdx6通过增强硒蛋白(尤其GPx4)表达和活性抑制铁死亡,其缺陷则降低硒蛋白水平并促进铁死亡。
临床怎么用
- 天然激活剂和靶向Prdx6的治疗策略可能有助于维护眼晶状体健康并延缓白内障发展。
局限性
- Prdx6调控细胞死亡与存活的具体分子机制,尤其在衰老和氧化应激致白内障条件下,尚不清楚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Selenium-independent peroxiredoxin 6 (Prdx6) is a unique member of the peroxiredoxin family, which protects cells from various stressors by regulating reactive oxygen species (ROS) and maintaining survival signaling. As a multifunctional "moonlighting" protein, Prdx6 exhibits glutathione peroxidase (GPx), acidic calcium-independent phospholipase A2, and lysophosphatidylcholine acyltransferase activities, enabling it to reduce ROS. Loss of Prdx6, owing to dysregulation of its transactivator nuclear factor erythroid 2-related factor 2 or aberrant oxidative post-translational modifications from aging or oxidative stress, disrupts cellular homeostasis and triggers inflammatory or non-inflammatory cell death, including apoptosis and pyroptosis. Similar to GPx4, Prdx6 exhibits selenium-independent peroxidase activity and possesses phospholipid hydroperoxide-reducing GPx activity. A novel function of Prdx6 in facilitating selenium utilization was identified recently; that is, it enhances the expression and activity of selenoproteins, especially GPx4, and prevents ferroptosis. Conversely, Prdx6 deficiency reduces selenoprotein levels and promotes ferroptosis. Nevertheless, the molecular mechanisms through which Prdx6 modulates cell death and survival, particularly under aging and oxidative stress conditions contributing to cataractogenesis, remain unclear. In this review, we summarize the current knowledge of Prdx6 regulation and activity during oxidative stress and aging, highlighting its role in inflammatory and non-inflammatory signaling that contributes to eye lens pathology and cataract formation. Additionally, we discuss natural activators and potential therapeutic strategies targeting Prdx6 to extend eye lens health and delay or prevent cataract development. Overall, we conclude that enhancing Prdx6 activity offers a promising strategy to prevent or reverse age-related cataracts.
引用
- Kubo E, Chhunchha B, Singh DP, et al. Aging, oxidative stress, and cataracts: Therapeutic prospects and translational insights into peroxiredoxin 6. Prog Retin Eye Res. 2026. PMID: 41577330. doi:10.1016/j.preteyeres.2026.101444
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。